PSYCH-AID
Advanced Immuno-neuro-endocrine Diagnostics in Psychiatry
| Coordinatore | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
| Nazionalità Coordinatore | Netherlands [NL] |
| Totale costo | 3˙649˙514 € |
| EC contributo | 3˙649˙514 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2011-IAPP |
| Funding Scheme | MC-IAPP |
| Anno di inizio | 2012 |
| Periodo (anno-mese-giorno) | 2012-06-01 - 2016-05-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | coordinator | 1˙226˙984.00 |
| 2 |
PSYNOVA NEUROTECH LTD
Organization address
address: "ST JOHN S INNOVATION CENTRE, COWLEY ROAD" contact info |
UK (CAMBRIDGE) | participant | 954˙439.00 |
| 3 |
RADIOLOGY MORPHOLOGICAL SOLUTIONS BV
Organization address
address: VELDSPAAT 36 contact info |
NL (BERKEL EN RODENRIJS) | participant | 458˙164.00 |
| 4 |
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Organization address
address: GESCHWISTER SCHOLL PLATZ 1 contact info |
DE (MUENCHEN) | participant | 309˙255.00 |
| 5 |
Advanced Practical Diagnostics
Organization address
address: Hertoginstraat 82 contact info |
BE (Turnhout) | participant | 212˙433.00 |
| 6 |
EDI EXPERIMENTELLE UND DIAGNOSTISCHE IMMUNOLOGIE GMBH
Organization address
address: ASPENHAUSTRASSE 25 contact info |
DE (REUTLINGEN) | participant | 193˙822.00 |
| 7 |
GENEURO INNOVATION SAS
Organization address
address: AVENUE ROCKEFELLER 60 contact info |
FR (LYON) | participant | 124˙958.00 |
| 8 |
ACADEMISCH ZIEKENHUIS GRONINGEN
Organization address
address: Hanzeplein 1 contact info |
NL (GRONINGEN) | participant | 73˙831.00 |
| 9 |
WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Organization address
address: SCHLOSSPLATZ 2 contact info |
DE (MUENSTER) | participant | 67˙620.00 |
| 10 |
Foundation Biological Psychiatry
Organization address
address: Svilenitsa str 8 contact info |
BG (Sofia) | participant | 28˙008.00 |
| 11 |
CROSSLINKS BV
Organization address
address: WILLEMSKADE 18C contact info |
NL (ROTTERDAM) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The current diagnosis of psychiatric disorders such as schizophrenia and mood disorders, is highly subjective, due to the lack of empirical markers or objective tests specific for these diseases. PSYCH-AID searchers to fill the gap thrpugh the in-parallel study of schizophrenia and mood disorder patients combining, validating and registering 4 sets of biomarker tests already in advanced stage of development in two other EU-FP7 projects of partners (MOODINFLAME and SchizDX). Biomarkers are based on activated immune response system in conjunction with an abnormal neuro-endocrine set point. PSYCH-AID aims at the developm,ent of clinically applicable blood assays identifying pateints/individuals with such activated set points by combining the efforts of academia and industry. PSYCH-AID unites 9 European partners excelling in this field: 5 academia and 5 SMEs. The intersectoral and interdisciplinary collaboration and exchange of researchers will foster the translation of fundamental clinical research into practical solutions for the diagnosis and treatment of people affected by schizophrenia or mood disorders. This fit perfectly with the IAPP scheme. PSYCH-AID contributes to building a long lasting collaboration between the partners, the first consortium in the world to put objective diagnostic and prognostic tests for psychiatric disorders into practice. European industry will benefit from this competitive lead. Since the disorders have a serious impact on the quality of life of the individuals affected, an improved diagnosis and prognosis will substantially contribute to improving their quality of life. Furthermore, PSYCH-AID gives the researchers involved a platform to acquire complementary skills, thus ameliorating their professional career opportunities.'
Introduzione (Teaser)
Currently, diagnosis of psychiatric disorders such as schizophrenia (SZ) and mood disorders is highly subjective. EU-funded researchers are working on validating combined biomarker panels for accurate diagnosis of such disorders.